R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000494:pharmacology*; D002219:Carbamates / Q000494:pharmacology / Q000627:therapeutic use; D003561:Cytarabine / Q000494:pharmacology* / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D007939:Leukemia L1210 / Q000188:drug therapy / Q000473:pathology*; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000473:pathology*; D051379:Mice; D008938:Mitosis / Q000187:drug effects*
D000970:Antineoplastic Agents; D001562:Benzimidazoles; D002219:Carbamates; D003561:Cytarabine